Evaluating Viloxazine ER (Qelbree) Administered with Psychostimulants For Pediatric ADHD: Analysis of a Phase 4 Safety Trial

Authors
Category Primary study
ConferenceNeuroscience Education Institute Congress, NEI 2023
Year 2024
This article has no abstract
Epistemonikos ID: 98db52b5fbafb96c4a5d50d42f7ae8ec38445ecb
First added on: Apr 19, 2025